Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 29, 2025
Reporting Period: The filing references financial information for the three months ended March 31, 2025, and forward-looking statements for 2025 and beyond.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. It states that financial information for the three months ended March 31, 2025, is attached as Exhibit 99.1 and incorporated by reference. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not detail specific material changes versus prior periods. It indicates that such information is contained within the press release dated April 29, 2025, which is filed as Exhibit 99.1.
Guidance, Outlook, and Risks
Outlook: The filing incorporates forward-looking statements relating to 2025 and beyond, as presented in the referenced press release.
Legal Status: The information furnished pursuant to Item 2.02 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It shall not be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 to obtain the actual financial figures for the three months ended March 31, 2025.
- Read the press release dated April 29, 2025, for specific forward-looking statements and management commentary.
- Verify the company's current liquidity and debt positions, as these are not disclosed in the cover sheet text.
- Note that the financial data in this filing is furnished but not "filed" for liability purposes under Section 18 of the Exchange Act.